A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study.

Authors:
Chen LZ; Roos D; Philip E; Werth EG; Kostuk S and 2 more

Journal:
Pharmaceuticals (Basel)

Publication Year: 2024

DOI:
10.3390/ph17020193

PMCID:
PMC10893151

PMID:
38399408

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synth…
Elsawi AE; Shahin MI; Elbendary HA and 3 more (2024) - Transparency Score: 3/6
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F and 1 more (2024) - Transparency Score: 3/6
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.
Zhang C; Su H; Waight E and 4 more (2024) - Transparency Score: 3/6
A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Cr…
Kokoszka A. (2024) - Transparency Score: 3/6
A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease…
Kalsoom S; Rasool MF; Imran I and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest Author Linzhi Chen, David Roos, Elsy Philip, Emily Werth, Stephanie Kostuk, Hongbin Yu were employed by the company Boehringer Ingelheim Pharmaceuticals, Inc. Author Holger Fuchs was employed by the company Boehringer Ingelheim Pharma GmbH & Co. KG."

Evidence found in paper:

"The study was funded entirely by Boehringer Ingelheim. The authors declare that no writing assistance was utilized in the production of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025